A. T. Holder

728 total citations
26 papers, 566 citations indexed

About

A. T. Holder is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, A. T. Holder has authored 26 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in A. T. Holder's work include Growth Hormone and Insulin-like Growth Factors (15 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). A. T. Holder is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (15 papers), Glycosylation and Glycoproteins Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). A. T. Holder collaborates with scholars based in United Kingdom, India and United States. A. T. Holder's co-authors include M A Preece, R. Aston, Michael Wallis, P. C. Bates, Juraj Iványi, David J. Morrell, Michael A. Preece, Eugenio Spencer, R. D. G. Milner and David Hill and has published in prestigious journals such as Endocrinology, Molecular Endocrinology and Journal of Endocrinology.

In The Last Decade

A. T. Holder

25 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. T. Holder United Kingdom 15 345 228 160 65 61 26 566
Carol J. Mirell United States 10 224 0.6× 271 1.2× 119 0.7× 41 0.6× 35 0.6× 15 630
Stephen R. Lasky United States 10 423 1.2× 382 1.7× 141 0.9× 17 0.3× 66 1.1× 12 692
Yvonne W.-H. Yang United States 11 384 1.1× 308 1.4× 98 0.6× 18 0.3× 81 1.3× 14 567
GE-MING LUI United States 8 105 0.3× 223 1.0× 78 0.5× 46 0.7× 29 0.5× 8 502
Björn E. Wenzel Germany 11 181 0.5× 158 0.7× 117 0.7× 73 1.1× 19 0.3× 17 619
Donald E. Fleenor United States 14 106 0.3× 248 1.1× 77 0.5× 16 0.2× 93 1.5× 20 503
M Ross Australia 8 445 1.3× 347 1.5× 131 0.8× 15 0.2× 68 1.1× 9 554
Yucheng Liao China 8 214 0.6× 347 1.5× 189 1.2× 13 0.2× 35 0.6× 9 604
Susan Samaras United States 17 381 1.1× 300 1.3× 231 1.4× 9 0.1× 253 4.1× 28 881
Stanley E. Hansen Japan 5 147 0.4× 256 1.1× 309 1.9× 19 0.3× 189 3.1× 7 772

Countries citing papers authored by A. T. Holder

Since Specialization
Citations

This map shows the geographic impact of A. T. Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. T. Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. T. Holder more than expected).

Fields of papers citing papers by A. T. Holder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. T. Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. T. Holder. The network helps show where A. T. Holder may publish in the future.

Co-authorship network of co-authors of A. T. Holder

This figure shows the co-authorship network connecting the top 25 collaborators of A. T. Holder. A scholar is included among the top collaborators of A. T. Holder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. T. Holder. A. T. Holder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilimoria, Karl Y., Lesly A. Dossett, Adil H. Haider, et al.. (2025). Leadership in Action: Tales From the Trenches. Journal of Surgical Research. 315. 1013–1016.
2.
Ferasin, Luca, Gianfranco Gabai, James Beattie, G Bono, & A. T. Holder. (1997). Enhancement of FSH bioactivity in vivo using site-specific antisera. Journal of Endocrinology. 152(3). 355–363. 11 indexed citations
3.
Borromeo, V., et al.. (1996). Growth hormone stimulates the secretion of insulin-like growth factor binding protein-2 (IGFBP-2) by monolayer cultures of sheep costal growth plate chondrocytes. Molecular and Cellular Biochemistry. 162(2). 145–51. 14 indexed citations
4.
Holder, A. T., et al.. (1995). Immunomodulation of the growth hormone — IGF-I axis. Livestock Production Science. 42(2-3). 229–237. 8 indexed citations
5.
Beattie, James & A. T. Holder. (1994). Location of an epitope defined by an enhancing monoclonal antibody to growth hormone: some structural details and biological implications.. Molecular Endocrinology. 8(8). 1103–1110. 15 indexed citations
6.
Glencross, R. G., R. D. Lovell, & A. T. Holder. (1993). MONOCLONAL ANTIBODY ENHANCEMENT OF FSH-INDUCED UTERINE GROWTH IN SNELL DWARF MICE. Journal of Endocrinology. 136(3). R5–R7. 14 indexed citations
7.
Bates, P. C., R. Aston, & A. T. Holder. (1992). Growth hormone control of tissue protein metabolism in dwarf mice: enhancement by a monoclonal antibody. Journal of Endocrinology. 132(3). 369–375. 10 indexed citations
8.
Pell, J. M., I. D. Johnsson, David J. Morrell, et al.. (1989). POTENTIATION OF GROWTH HORMONE ACTIVITY IN SHEEP USING MCNCCLCNAL ANTIBODIES. Journal of Endocrinology. 120(2). R15–R18. 27 indexed citations
9.
Morrell, David J., et al.. (1989). A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor. Journal of Molecular Endocrinology. 2(3). 201–206. 61 indexed citations
10.
Aston, R., A. T. Holder, Michael Wallis, P. C. Bates, & R. Bomford. (1988). Enhancement of growth hormone activity in vivo by monoclonal antibodies: potential for autoimmunization. Proceedings of The Nutrition Society. 47(3). 387–395. 3 indexed citations
11.
Bates, P. C. & A. T. Holder. (1988). The anabolic actions of growth hormone and thyroxine on protein metabolism in Snell dwarf and normal mice. Journal of Endocrinology. 119(1). 31–41. 28 indexed citations
12.
Holder, A. T., et al.. (1988). Monoclonal antibody enhancement of the effects of human growth hormone on growth and body composition in mice. Journal of Endocrinology. 117(1). 85–90. 23 indexed citations
13.
Aston, R., A. T. Holder, M A Preece, & Juraj Iványi. (1986). Potentiation of the somatogenic and lactogenic activity of human growth hormone with monoclonal antibodies. Journal of Endocrinology. 110(3). 381–388. 41 indexed citations
14.
Holder, A. T., R. Aston, M A Preece, & Juraj Iványi. (1985). MONOCLONAL ANTIBODY-MEDIATED ENHANCEMENT OF GROWTH HORMONE ACTIVITY IN VIVO. Journal of Endocrinology. 107(3). R9–R12. 42 indexed citations
16.
Clark, Ross & A. T. Holder. (1984). Ovarian–splenic autotransplantation: evidence that oestrogen does not inhibit hepatic somatomedin generation. Journal of Endocrinology. 103(1). 43–47. 4 indexed citations
17.
Holder, A. T., Ross Clark, & M A Preece. (1983). Prolonged oestrogen treatment inhibits growth hormone-induced growth in hypopituitary dwarf mice. Journal of Endocrinology. 96(3). 451–456. 4 indexed citations
18.
Dunger, David B., et al.. (1982). Growth and endocrine changes in the hepatic glycogenoses. European Journal of Pediatrics. 138(3). 226–230. 25 indexed citations
19.
Holder, A. T., Michael A. Preece, & Marianne Wallis. (1981). EFFECT OF GLUCOCORTICOIDS, BUTANOL EXTRACTION OF SERUM AND ADRENALECTOMY ON SOMATOMEDIN LEVELS IN THE RAT. Journal of Endocrinology. 90(3). 411–420. 1 indexed citations
20.
Holder, A. T. & Michael Wallis. (1977). ACTIONS OF GROWTH HORMONE, PROLACTIN AND THYROXINE ON SERUM SOMATOMEDIN-LIKE ACTIVITY AND GROWTH IN HYPOPITUITARY DWARF MICE. Journal of Endocrinology. 74(2). 223–229. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026